Award
National Cancer Institute 5R01CA278802-04
TLR5 enhancement of liver-directed radiotherapy plus immune checkpoint blockade against irradiated liver metastasis and abscopal tumors
Recipient
Roswell Park Cancer Institute
Award Amount
$698,501.00
Ceiling
$698,501.00
Awarded
June 18, 2026
Identifier
5R01CA278802-04
Research project funded by NIH/NCI to enhance liver-directed radiotherapy combined with immune checkpoint blockade targeting TLR5 pathway to improve survival in liver metastasis patients. Award amount is $698,501 for fiscal year 2026.
Description
This project involves research on enhancing liver-directed radiotherapy combined with immune checkpoint blockade, focusing on the TLR5 pathway and its role in antitumor immunity. The award is funded by the NIH/NCI with a total amount of $698,501 for the fiscal year 2026. The project aims to improve survival outcomes in patients with liver metastasis through innovative therapeutic strategies.